File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study

TitleBrivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study
Authors
Issue Date2013
PublisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Citation
Journal of Clinical Oncology, 2013, v. 31 n. 28, p. 3517-3524 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/193244
ISSN
2015 Impact Factor: 20.982
2015 SCImago Journal Rankings: 9.204
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJohnson, PJen_US
dc.contributor.authorQin, Sen_US
dc.contributor.authorPark, JWen_US
dc.contributor.authorPoon, RTPen_US
dc.date.accessioned2013-12-20T02:37:57Z-
dc.date.available2013-12-20T02:37:57Z-
dc.date.issued2013en_US
dc.identifier.citationJournal of Clinical Oncology, 2013, v. 31 n. 28, p. 3517-3524en_US
dc.identifier.issn0732-183X-
dc.identifier.urihttp://hdl.handle.net/10722/193244-
dc.languageengen_US
dc.publisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/-
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.titleBrivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL studyen_US
dc.typeArticleen_US
dc.identifier.emailPoon, RTP: poontp@hku.hken_US
dc.identifier.authorityPoon, RTP=rp00446en_US
dc.identifier.doi10.1200/JCO.2012.48.4410-
dc.identifier.pmid23980084-
dc.identifier.hkuros227171en_US
dc.identifier.volume31en_US
dc.identifier.issue28en_US
dc.identifier.spage3517en_US
dc.identifier.epage3524en_US
dc.identifier.isiWOS:000330539000010-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats